About DKMS

Shaping the future of our DKMS Group

The Foundation Board and global executive team are shaping the future of the DKMS Group.

04/01/2024

The Foundation Board and global executive team are advised by our Medical Council. They are responsible for setting the strategic direction of our DKMS Group at an international level. As consultants, they also provide advice and support to our management teams at the entities in the development of local strategies.

Chief Executive Officer: Dr. Elke Neujahr

Elke Neujahr

In 2018, Elke Neujahr rejoined a cause that had long been close to her heart by becoming Global CEO of the DKMS Group, as well as Executive Vice-Chairwoman of the Board of Directors in the US and Chairwoman of the board in Poland, United Kingdom and South Africa.

“Every year, tens of thousands of donor searches are initiated across the globe. At DKMS, we are working to ensure that every patient in need finds a matching donor. Our mission is driven by the countless employees, for whom this is a matter close to the heart, and the millions of compassionate individuals across the world who we are proud to call our donors."

With a doctorate in communication sciences, Elke served national and international executives as an expert in all questions of corporate reputation, crisis, and change management. Initially holding a variety of positions in the industry, Elke ultimately switched to the consulting side of the corporate communications business. She has been Partner and CEO of a leading European PR Consultancy before she successfully ran her own company for 15 years. With 40 years of expertise in general management, she drives the development of the DKMS Group.

As the Global CEO, Elke oversees all DKMS operations and the organisation’s continued international expansion.

“Aware of the need for a multifaceted approach, we will continue to extend our mission and are currently investing in providing access to transplantation. The only effective way to address blood cancer and other life-threatening blood diseases is with a macro perspective that ensures no patient is left behind, regardless of their geographic location or socio-economic status.”

Follow Elke Neujahr on Twitter and Linkedin.

Chief Medical Officer: Dr. Alexander Schmidt

David Means

Dr. Alexander Schmidt has been Managing Director and the Chief Medical Officer of DKMS since 2013. He is responsible for all areas that provide professional information and advice as well as coordination and support for donors before, during and after a donation, thus ensuring safe bone marrow and peripheral blood stem cell donations.

In addition, Alexander oversees the ongoing relationship management with transplant centres, search units and registries and the medical advice for all international DKMS entities. He and his teams are also responsible for various quality programs and scientific projects.

Alexander holds a doctorate in mathematics and medicine. After working as an intern at Heidelberg University Hospital, he worked as a management consultant with a focus on health care issues. He has been working for DKMS since 2002 in various management positions. He is also the Chief Executive Officer of the DKMS Life Science Lab and the DKMS Stem Cell Bank and Chief Scientific Officer of the DKMS Registry.

Chief Financial Officer: Bernd Weinel

Chief Financial Officer

Bernd Weinel has joined DKMS in 2023 as Managing Director and Chief Financial Officer. He oversees finance and accounting as well as the administration and management of the DKMS entities.

Bernd studied business administration at the Goethe University Frankfurt and thereafter working many years in international companies including several years in Spain.

He brings many years of experience as an interim manager for outstanding assignments in the areas of Finance, Controlling, M&A and Restructuring as well as CFO and Finance Director in the medical technology, media, consumer goods, manufacturing and chemical industries.